Cleveland Clinic Diabetes Therapeutics, Technology and Surgery 2021

Cleveland Clinic Diabetes Therapeutics, Technology and Surgery 2021

YOU WILL GET THE COURSE VIA LIFETIME DOWNLOAD LINK (FAST SPEED) AFTER PAYMENT

For over twenty five years, Cleveland Clinic has been at the forefront of diabetes treatment, research and education.  Its world class faculty has designed Diabetes Therapeutics, Technology and Surgery to provide up-to-date reviews of management strategies and research on the complications of this disease.  It includes a detailed analysis of therapeutic options applicable to type 1 and type 2 diabetes, as well as their complications

Diabetes Day, Therapeutics, Technology and Surgery, is presented by the Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism to provide up-to-date reviews of management strategies and research on the complications of diabetes. Key topic areas that will be addressed include a review of therapeutic options to manage both type 1 and 2 diabetes and the complications, including a pump update, dual hormone therapies, sulfonylureas, GLP1 agonists, metformin, and the role of exercise and fasting. New this year is a discussion of the pathophysiologic impact of COVID-19. The goal of this course is to increase practitioners’ competence and clinical performance to treat diabetes and its complications and, ultimately, to improve patient outcomes.

In addition to receiving speaker slides both pre and post course, participants will be given access to the live stream recording post course.

After participating in this live stream activity, practitioners will be able to:

• Describe the efficacy and side effects of therapeutic innovations for type 1 diabetes, including closed-loop insulin pumps, dual hormone therapy, and glucagon.
• Compare the effectiveness of new and emerging therapies for both type 1 and 2 diabetes.
• Critically appraise the impact of bariatric surgery on patients with type 2 diabetes.
• Describe options for treating children with type 2 diabetes.
• Compare the data on effectiveness of diets and exercise in diabetes strategies.
• Summarize research defining the pathophysiologic impact of nonalcoholic steatohepatitis.
• Describe how COVID-19 affects the progression of diabetes in infected patients.

Cleveland Clinic Diabetes Therapeutics, Technology and Surgery

---

Session 1: Type 1 Diabetes Corner

Pump Update	Diana Isaacs, PharmD, BCPS, BC-ADM, CDE
Dual Hormone Pumps	Keren Zhou, MD
Do It Yourself Technology	Julia Blanchette, PhD, RN, CDCES
New Insulins	Robert S. Zimmerman, MD
Dawn of Glucagon	Vinni Makin, MD

Session 2: Focus on Type 2 Diabetes

Cardiovascular Outcomes of Bariatric Surgery in Patients with Obesity and Diabetes	Ali Aminian, MD
Are Sulfonyureas Safe?	Pratibha Rao, MD
Treatment of Type 2 Diabetes in Children	Jamie Wood, MD
New Treatment Options for Diabetes and the Kidney	Alexandra Mikhael, MD
GLP-1 Agonists: Oral VS. SubQ	Mario Skugor, MD
Non-Alcoholic Fatty Liver Disease (NAFLD) Is an Early Manifestion of the Metabolic Syndrome	Adi Mehta, MD
Treatment of Hyperlipidemia in Type 2 Diabetes: Review of Current Guidelines	Dennis Bruemmer, MD, PhD

Session 3: Fasting, Metformin and Management Issues

Intermittent Fasting and Diabetes: What’s the Evidence?	Carolyn Garvey, RDN, LD, CDCES
Management of Hypoglycemia Post Gastric Bypass	Sangeeta Kashyap, MD
Role of Exercise in Management of Diabetes	Oscar Morey Vargas, MD
Understanding Metformin’s Actions Through the Interactions in the Gut	Leann Olansky, MD
T2D and CVD: Metformin Monotherapy	Kevin M. Pantalone, DO, ECNU, FACE
Diabetes Management in Patients with COVID-19	Sana Hasan, DO
Endoscopic and Surgical Division of the Gastric Pylorus for Gastroparesis	Joshua Landreneau, MD

Release Date: 7/1/21